Suppr超能文献

CO-OP 方法治疗帕金森病的疗效和可行性:随机对照试验研究方案。

Efficacy and Feasibility of the CO-OP Approach in Parkinson's Disease: RCT Study Protocol.

出版信息

Can J Occup Ther. 2023 Dec;90(4):363-373. doi: 10.1177/00084174231156287. Epub 2023 Feb 13.

Abstract

Parkinson's disease (PD) leads to cognitive dysfunction which limits participation and occupational performance. Cognitive Orientation to Daily Occupational Performance (CO-OP) approach is effective in other adult neurological populations and warrants investigation in PD. To describe a study protocol evaluating the preliminary efficacy and feasibility of CO-OP approach in PD. A randomised controlled trial (RCT) with adults with PD was assigned to either: CO-OP training-intensive (CO-OP-I, 20 sessions) or waitlist control (WLC) followed by CO-OP-standard (CO-OP-S, 10 sessions). Occupational performance and satisfaction of adults with PD in chosen goals. Measures will be obtained at baseline, post-intervention, and 3-month follow-up. As the first RCT focused on CO-OP in PD, this trial will provide evidence for the potential of this approach in PD and lay the groundwork for future large-scale trials. Australian New Zealand Clinical Trials registry, ACTRN12621001483842. Registered November 1, 2021; retrospectively registered 3 months after commencement.

摘要

帕金森病(PD)可导致认知功能障碍,限制患者的参与和职业表现。认知导向日常生活作业疗法(CO-OP)在其他成年神经病患者群体中具有疗效,值得在 PD 中进行研究。本研究旨在描述一项评估 CO-OP 方法在 PD 中的初步疗效和可行性的研究方案。这是一项针对 PD 成人患者的随机对照试验(RCT),患者被随机分配至 CO-OP 强化训练组(CO-OP-I,20 次)或等待名单对照组(WLC,随后进行 CO-OP 标准训练组,CO-OP-S,10 次)。评估 CO-OP 对 PD 患者选择目标的职业表现和满意度的影响。将在基线、干预后和 3 个月随访时进行测量。由于这是第一项针对 PD 患者的 CO-OP 的 RCT,该试验将为该方法在 PD 中的潜力提供证据,并为未来的大规模试验奠定基础。澳大利亚新西兰临床试验注册中心,ACTRN12621001483842。于 2021 年 11 月 1 日注册;在开始后 3 个月进行了回顾性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9ee/10647899/1e1827fa2b08/10.1177_00084174231156287-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验